Home LiteratureArticle Details
PMID: 10900196 Published · ppublish English Comparative Study Journal Article Research Support, U.S. Gov't, P.H.S.

Single cell Ras-GTP analysis reveals altered Ras activity in a subpopulation of neurofibroma Schwann cells but not fibroblasts.

The Journal of biological chemistry ·Vol. 275 ·No. 39 ·2000-09-29 ·Pages 30740-5

Sherman LS, Atit R, Rosenbaum T, Cox AD, Ratner N

Abstract

Neurofibromatosis type 1 (NF1) is a common genetic disorder characterized by multiple neurofibromas, peripheral nerve tumors containing mainly Schwann cells and fibroblasts. The NF1 gene encodes neurofibromin, a tumor suppressor postulated to function in part as a Ras GTPase-activating protein. The roles of different cell types and of elevated Ras-GTP in neurofibroma formation are unclear. To determine which neurofibroma cell type has altered Ras-GTP regulation, we developed an immunocytochemical assay for active, GTP-bound Ras. In NIH 3T3 cells, the assay detected overexpressed, constitutively activated K-, N-, and Ha-Ras and insulin-induced endogenous Ras-GTP. In dissociated neurofibroma cells from NF1 patients, Ras-GTP was elevated in Schwann cells but not fibroblasts. Twelve to 62% of tumor Schwann cells showed elevated Ras-GTP, unexpectedly revealing neurofibroma Schwann cell heterogeneity. Increased basal Ras-GTP did not correlate with increased cell proliferation. Normal human Schwann cells, however, did not demonstrate elevated basal Ras activity. Furthermore, compared with cells from wild type littermates, Ras-GTP was elevated in all mouse Nf1(-/-) Schwann cells but never in Nf1(-/-) mouse fibroblasts. Our results indicate that Ras activity is detectably increased in only some neurofibroma Schwann cells and suggest that neurofibromin is not an essential regulator of Ras activity in fibroblasts.

MeSH Terms
Animals Cell Separation Fibroblasts/chemistry Glutathione Transferase/genetics,metabolism Guanosine Triphosphate/isolation & purification Histocytochemistry/methods Mice Mice, Mutant Strains Nerve Tissue Proteins/genetics Neurofibroma/chemistry,pathology Neurofibromin 1 Peptide Fragments/genetics,metabolism Protein Binding Proto-Oncogene Proteins c-raf/genetics,metabolism Recombinant Fusion Proteins/genetics,metabolism Schwann Cells/chemistry ras GTPase-Activating Proteins/genetics ras Proteins/isolation & purification
Chemicals
Nerve Tissue Proteins Neurofibromin 1 Peptide Fragments Recombinant Fusion Proteins ras GTPase-Activating Proteins Guanosine Triphosphate Glutathione Transferase Proto-Oncogene Proteins c-raf ras Proteins
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Sherman L S
Department of Cell Biology, Neurobiology and Anatomy, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267-0521, USA.
Atit R
Rosenbaum T
Cox A D
Ratner N
References (52)
52 references, click to expand
  1. Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues.
    Genes Dev. 1994 May 1;8(9):1019-29 PMID: 7926784
  2. Inactivation of the NF1 gene in human melanoma and neuroblastoma cell lines without impaired regulation of GTP.Ras.
    Proc Natl Acad Sci U S A. 1993 Jun 15;90(12):5539-43 PMID: 8516298
  3. Fibroblasts of neurofibromatosis type 1 showed no abnormality in p21ras-mediated response to serum in culture.
    J Dermatol Sci. 1994 Apr;7(2):96-9 PMID: 8060920
  4. Differential expression of two mRNA species indicates a dual function of peripheral myelin protein PMP22 in cell growth and myelination.
    J Neurosci Res. 1994 Mar 1;37(4):529-37 PMID: 8021974
  5. Loss of the normal NF1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders.
    N Engl J Med. 1994 Mar 3;330(9):597-601 PMID: 8302341
  6. Neurofibromin can inhibit Ras-dependent growth by a mechanism independent of its GTPase-accelerating function.
    Mol Cell Biol. 1994 Jan;14(1):641-5 PMID: 8264632
  7. Selective inhibition of ras-dependent transformation by a farnesyltransferase inhibitor.
    Science. 1993 Jun 25;260(5116):1934-7 PMID: 8316833
  8. Analysis of Ras protein expression in mammalian cells.
    Methods Enzymol. 1995;255:195-220 PMID: 8524103
  9. Farnesyltransferase inhibitors block the neurofibromatosis type I (NF1) malignant phenotype.
    Cancer Res. 1995 Aug 15;55(16):3569-75 PMID: 7627966
  10. Neurofibromin-deficient fibroblasts fail to form perineurium in vitro.
    Development. 1995 Nov;121(11):3583-92 PMID: 8582272
  11. Nf1 deficiency causes Ras-mediated granulocyte/macrophage colony stimulating factor hypersensitivity and chronic myeloid leukaemia.
    Nat Genet. 1996 Feb;12(2):137-43 PMID: 8563750
  12. Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells.
    Nat Genet. 1996 Feb;12(2):144-8 PMID: 8563751
  13. Co-purification and direct interaction of Ras with caveolin, an integral membrane protein of caveolae microdomains. Detergent-free purification of caveolae microdomains.
    J Biol Chem. 1996 Apr 19;271(16):9690-7 PMID: 8621645
  14. Ras-GTP levels are elevated in human NF1 peripheral nerve tumors.
    Oncogene. 1996 Feb 1;12(3):507-13 PMID: 8637706
  15. Identification of NF1 mutations in both alleles of a dermal neurofibroma.
    Nat Genet. 1996 Sep;14(1):110-2 PMID: 8782831
  16. Cell cycle-dependent activation of Ras.
    Curr Biol. 1996 Dec 1;6(12):1621-7 PMID: 8994826
  17. Nf1-deficient mouse Schwann cells are angiogenic and invasive and can be induced to hyperproliferate: reversion of some phenotypes by an inhibitor of farnesyl protein transferase.
    Mol Cell Biol. 1997 Feb;17(2):862-72 PMID: 9001241
  18. Minimal Ras-binding domain of Raf1 can be used as an activation-specific probe for Ras.
    Oncogene. 1997 Feb 6;14(5):623-5 PMID: 9053862
  19. Aberrant Ras regulation and reduced p190 tyrosine phosphorylation in cells lacking p120-Gap.
    Mol Cell Biol. 1997 Apr;17(4):1840-7 PMID: 9121432
  20. Rescue of a Drosophila NF1 mutant phenotype by protein kinase A.
    Science. 1997 May 2;276(5313):791-4 PMID: 9115203
  21. Requirement of Drosophila NF1 for activation of adenylyl cyclase by PACAP38-like neuropeptides.
    Science. 1997 May 2;276(5313):795-8 PMID: 9115204
  22. Homozygous inactivation of the NF1 gene in bone marrow cells from children with neurofibromatosis type 1 and malignant myeloid disorders.
    N Engl J Med. 1997 Jun 12;336(24):1713-20 PMID: 9180088
  23. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2.
    JAMA. 1997 Jul 2;278(1):51-7 PMID: 9207339
  24. Confirmation of a double-hit model for the NF1 gene in benign neurofibromas.
    Am J Hum Genet. 1997 Sep;61(3):512-9 PMID: 9326316
  25. Increasing complexity of the Ras signaling pathway.
    J Biol Chem. 1998 Aug 7;273(32):19925-8 PMID: 9685325
  26. Ruffling membrane, stress fiber, cell spreading and proliferation abnormalities in human Schwannoma cells.
    Oncogene. 1998 Oct 29;17(17):2195-209 PMID: 9811451
  27. The Nf1 tumor suppressor regulates mouse skin wound healing, fibroblast proliferation, and collagen deposited by fibroblasts.
    J Invest Dermatol. 1999 Jun;112(6):835-42 PMID: 10383727
  28. Caveolin-1 expression in Schwann cells.
    Glia. 1999 Jul;27(1):39-52 PMID: 10401631
  29. Loss of NF1 allele in Schwann cells but not in fibroblasts derived from an NF1-associated neurofibroma.
    Genes Chromosomes Cancer. 1999 Mar;24(3):283-5 PMID: 10451710
  30. Dominant-negative caveolin inhibits H-Ras function by disrupting cholesterol-rich plasma membrane domains.
    Nat Cell Biol. 1999 Jun;1(2):98-105 PMID: 10559881
  31. Mouse models of tumor development in neurofibromatosis type 1.
    Science. 1999 Dec 10;286(5447):2172-6 PMID: 10591652
  32. Culture of cytogenetically abnormal schwann cells from benign and malignant NF1 tumors.
    Genes Chromosomes Cancer. 2000 Feb;27(2):117-23 PMID: 10612798
  33. Farnesyltransferase inhibitors: antineoplastic mechanism and clinical prospects.
    Curr Opin Cell Biol. 2000 Apr;12(2):166-73 PMID: 10712917
  34. Short communication: neurofibromatosis fibroblasts: slow growth and abnormal morphology.
    Pediatr Res. 1981 Mar;15(3):290-3 PMID: 6784099
  35. Inhibition of farnesyltransferase induces regression of mammary and salivary carcinomas in ras transgenic mice.
    Nat Med. 1995 Aug;1(8):792-7 PMID: 7585182
  36. Schwann cells from neurofibromin deficient mice exhibit activation of p21ras, inhibition of cell proliferation and morphological changes.
    Oncogene. 1995 Jul 20;11(2):325-35 PMID: 7624147
  37. Ras-GTP regulation is not altered in cultured melanocytes with reduced levels of neurofibromin derived from patients with neurofibromatosis 1 (NF1).
    Biol Chem Hoppe Seyler. 1995 Feb;376(2):91-101 PMID: 7794530
  38. The 2.2 A crystal structure of the Ras-binding domain of the serine/threonine kinase c-Raf1 in complex with Rap1A and a GTP analogue.
    Nature. 1995 Jun 15;375(6532):554-60 PMID: 7791872
  39. Quantitative analysis of the complex between p21ras and the Ras-binding domain of the human Raf-1 protein kinase.
    J Biol Chem. 1995 Feb 17;270(7):2901-5 PMID: 7852367
  40. Neurofibromatosis tumor and skin cells in culture. II. Structural proteins with special reference to the cytoskeletal and cell surface components.
    Acta Neuropathol. 1984;63(4):269-75 PMID: 6433640
  41. Schwann-like cells cultured from human dermal neurofibromas. Immunohistological identification and response to Schwann cell mitogens.
    Ann N Y Acad Sci. 1986;486:227-40 PMID: 3032056
  42. Ras-mediated cell cycle arrest is altered by nuclear oncogenes to induce Schwann cell transformation.
    EMBO J. 1988 Jun;7(6):1635-45 PMID: 3049071
  43. Angiogenic and invasive properties of neurofibroma Schwann cells.
    J Cell Biol. 1990 Aug;111(2):645-53 PMID: 1696266
  44. The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements ira mutants of S. cerevisiae.
    Cell. 1990 Nov 16;63(4):835-41 PMID: 2121369
  45. The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21.
    Cell. 1990 Nov 16;63(4):843-9 PMID: 2121370
  46. The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins.
    Cell. 1990 Nov 16;63(4):851-9 PMID: 2121371
  47. Insulin stimulation of gene expression mediated by p21ras activation.
    EMBO J. 1991 May;10(5):1103-9 PMID: 2022184
  48. Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis.
    Cell. 1992 Apr 17;69(2):265-73 PMID: 1568246
  49. Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients.
    Nature. 1992 Apr 23;356(6371):713-5 PMID: 1570015
  50. Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis.
    Nat Genet. 1993 Feb;3(2):122-6 PMID: 8499945
  51. Differential antagonism of Ras biological activity by catalytic and Src homology domains of Ras GTPase activation protein.
    Proc Natl Acad Sci U S A. 1993 Jun 1;90(11):4887-91 PMID: 8506332
  52. Tumour predisposition in mice heterozygous for a targeted mutation in Nf1.
    Nat Genet. 1994 Jul;7(3):353-61 PMID: 7920653
Article Info
Journal
The Journal of biological chemistry
Abbr.
J Biol Chem
ISSN
0021-9258
Published
2000-09-29
Pages
30740-5
Language
English
Region
United States
NLM ID
2985121R
PMCID
PMC3066458
Subset
IM
Grants
NCI NIH HHS · CA76092 · United States
NINDS NIH HHS · R01 NS028840-09 · United States
NINDS NIH HHS · R01 NS028840 · United States
NINDS NIH HHS · NS10297 · United States
NINDS NIH HHS · NS28840 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com